Assessment of HL7 FHIR Interoperability Between EHR Systems and the Survivorship Passport v2.0 Platform to Generate Treatment Summaries for Childhood Cancer Survivors in Six Clinics: Preliminary Testing Results.

Autores de IIS La Fe

• María Teresa Tormo Alcañiz

  Autor

• Lucas Cervero Beltran

  Autor

Participantes ajenos a IIS La Fe

• Saraceno, Davide
• Chronaki, Catherine
• Cangioli, Giorgio
• Filbert, Anna-Liesa
• Muraca, Monica
• Berti, Alessandra
• Rielli, Rita
• Thomopulos, Nikos
• Knoerr, Lisa
• Walz, Diana
• Neumann, Anke
• Beccaria, Andrea
• Aulicino, Anna
• Nicolas, Brigitte
• Cavalca, Giacomo
• Uyttebroeck, Anne
• van Helvoirt, Maria
• Brie, Tom
• Vanden Meersch, Erik
• Ladenstein, Ruth
• Bardi, Edit
• Schreier, Gunter
• Beyer, Stefan
• Mullner-Rieder, Markus
• Rascon, Jelena
• Kapitancuke, Monika
• Trinkunas, Justas
• Stukaite-Ruibiene, Egle
• Ragauskas, Paulius
• Ciesiuniene, Audrone
• Haupt, Riccardo
• Grabow, Desiree

Grupos

• Investigación Clínica y Traslacional en Cáncer

  

  Leader

  José Gómez Codina

Abstract

The Survivorship Passport (SurPass) for childhood cancer survivors provides a personalized treatment summary together with a care plan for long-term screening of possible late effects. HL7 FHIR connectivity of Electronic Health Record (EHR) systems with the SurPass has been proposed to reduce the burden of collecting and organizing the relevant information. We present the results of testing and validation efforts conducted across six clinics in Austria, Belgium, Germany, Italy, Lithuania, and Spain. We also discuss ways in which this experience can be used to reduce efforts for the SurPass integration in other clinics across Europe.

Keywords

• Cancer Survivorship; EHR systems; HL7 FHIR IG; Testing; Validation